Cargando…

Clopidogrel in Critically Ill Patients

Only limited data are available regarding the treatment of critically ill patients with clopidogrel. This trial investigated the effects and the drug concentrations of the cytochrome P450 (CYP450) activated prodrug clopidogrel (n = 43) and the half‐life of the similarly metabolized pantoprazole (n =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoergenhofer, Christian, Hobl, Eva‐Luise, Schellongowski, Peter, Heinz, Gottfried, Speidl, Walter S., Siller‐Matula, Jolanta M., Schmid, Monika, Sunder‐Plaßmann, Raute, Stimpfl, Thomas, Hackl, Matthias, Jilma, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813104/ https://www.ncbi.nlm.nih.gov/pubmed/28913918 http://dx.doi.org/10.1002/cpt.878

Ejemplares similares

Prasugrel in critically ill patients
por: Schoergenhofer, Christian, et al.
Publicado: (2017)

Acetylsalicylic acid in critically ill patients: a cross‐sectional and a randomized trial
por: Schoergenhofer, Christian, et al.
Publicado: (2017)

Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008)

Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers
por: Hobl, Eva-Luise, et al.
Publicado: (2015)

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing
por: Schoergenhofer, Christian, et al.
Publicado: (2018)

Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
por: Gelbenegger, Georg, et al.
Publicado: (2022)

Dissociation between systemic and pulmonary anti‐inflammatory effects of dexamethasone in humans
por: Bartko, Johann, et al.
Publicado: (2016)

The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
por: Ay, Cihan, et al.
Publicado: (2022)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
por: Gelbenegger, Georg, et al.
Publicado: (2019)

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis
por: Gelbenegger, Georg, et al.
Publicado: (2021)

Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis
por: Jorda, Anselm, et al.
Publicado: (2021)

Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
por: Hobl, Eva-Luise, et al.
Publicado: (2010)

Dysregulation of tissue and serum microRNAs in organ transplant recipients with cutaneous squamous cell carcinomas
por: Geusau, Alexandra, et al.
Publicado: (2020)

Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis
por: Jorda, Anselm, et al.
Publicado: (2022)

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
por: Ay, Cihan, et al.
Publicado: (2023)

A Single Lung Transplant in a Patient with Fabry Disease: Causality or Far-Fetched? A Case Report
por: Gaggl, Martina, et al.
Publicado: (2013)

Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
por: Gager, Gloria M., et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
por: Härtter, Sebastian, et al.
Publicado: (2012)

Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study
por: Sunder-Plassmann, Raute, et al.
Publicado: (2023)

Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy
por: Gaggl, Martina, et al.
Publicado: (2016)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)

Pharmacokinetic Modeling of Morphine’s Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers
por: Buszko, Katarzyna, et al.
Publicado: (2021)

Colistin dampens fibrinolysis and endothelial activation during endotoxaemia: A randomised, double blind trial
por: Schoergenhofer, Christian, et al.
Publicado: (2017)

Copeptin Predicts Mortality in Critically Ill Patients
por: Krychtiuk, Konstantin A., et al.
Publicado: (2017)

Interplay between Genetic and Clinical Variables Affecting Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention
por: Siller-Matula, Jolanta M., et al.
Publicado: (2014)

Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease
por: Gager, Gloria M., et al.
Publicado: (2022)

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
por: Li, Yi, et al.
Publicado: (2020)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
por: Gager, Gloria M., et al.
Publicado: (2021)

Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?
por: Jasiewicz, Małgorzata, et al.
Publicado: (2023)

Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
por: Aigner, Christof, et al.
Publicado: (2020)

Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A
por: Gelbenegger, Georg, et al.
Publicado: (2020)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
por: Karolyi, Mario, et al.
Publicado: (2021)

The use of frozen plasma samples in thromboelastometry
por: Schoergenhofer, Christian, et al.
Publicado: (2017)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Soluble neprilysin and survival in critically ill patients
por: Lenz, Max, et al.
Publicado: (2022)

3480 Association of Clopidogrel Resistance Determinants and MACE Ocurrence in Peripheral Arterial Disease
por: Nunez Medina, Hector Jose
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0g8qit3q616aogk94e578fhj2k